Fusion Pharmaceuticals Inc.
FUSNDelisted Jun 5, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001805890
Fusion Pharmaceuticals Inc. was delisted on Jun 5, 2024; its insiders filed their last Form 4 on Jun 4, 2024; 114 institutions reported holding it in 13F filings for Q1 2024, worth $1.47B in total; Duquesne Family Office was the only superinvestor holding it.
13F holders, Q4 2021
Institutional positions in Fusion Pharmaceuticals Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 32
- −7 vs. Q3 2021
- Shares held
- 27.8M
- +2.47M (+9.8%) vs. Q3 2021
- Total value
- $116.0M
- −$84.4M (−42.1%) vs. Q3 2021
- New holders
- 3
- 6 more added
- Sold out
- 10
- 8 more reduced
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FUSN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 114 | $1.47B |
| Q4 2023 | 77 | $584.1M |
| Q3 2023 | 41 | $129.8M |
| Q2 2023 | 41 | $235.1M |
| Q1 2023 | 38 | $171.9M |
| Q4 2022 | 30 | $88.9M |
| Q3 2022 | 34 | $80.3M |
| Q2 2022 | 31 | $69.4M |
| Q1 2022 | 28 | $219.1M |
| Q4 2021 | 32 | $116.0M |
| Q3 2021 | 40 | $220.6M |
| Q2 2021 | 39 | $221.8M |
| Q1 2021 | 38 | $295.9M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Fusion Pharmaceuticals Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Johnson & Johnson | 3,670,516 | $15.3M | 1.74% | 00.0% | Unchanged |
| FMR LLC | 3,229,966 | $13.5M | 0.00% | +3,495+0.1% | Added |
| OrbiMed Advisors LLC | 3,224,770 | $13.4M | 0.17% | 00.0% | Unchanged |
| Canada Pension Plan Investment Board | 3,116,966 | $13.0M | 0.01% | 00.0% | Unchanged |
| Adams Street Partners LLC | 2,947,809 | $12.3M | 1.88% | 00.0% | Unchanged |
| TPG GP A, LLC | 2,551,794 | $10.6M | 0.11% | +2,551,794 | New |
| Federated Hermes, Inc. | 1,574,000 | $6.56M | 0.01% | +120,110+8.3% | Added |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,598,377 | $6.51M | 2.72% | −20.0% | Reduced |
| Perceptive Advisors LLC | 1,227,017 | $5.12M | 0.08% | −27,590−2.2% | Reduced |
| Point72 Asset Management, L.P. | 1,048,956 | $4.37M | 0.02% | +190,944+22.3% | Added |
| Rock Springs Capital Management LP | 948,327 | $3.96M | 0.09% | 00.0% | Unchanged |
| 1832 Asset Management L.P. | 734,321 | $3.38M | 0.01% | 00.0% | Unchanged |
| Artal Group S.A. | 750,000 | $3.13M | 0.09% | 00.0% | Unchanged |
| Sio Capital Management, LLC | 259,763 | $1.08M | 0.33% | 00.0% | Unchanged |
| Victory Capital Management Inc | 250,380 | $1.04M | 0.00% | −17,323−6.5% | Reduced |
| Woodline Partners LP | 243,340 | $1.01M | 0.01% | +88,719+57.4% | Added |
| AlphaCentric Advisors LLC | 100,000 | $417.0K | 0.12% | +28,500+39.9% | Added |
| Sofinnova Investments, Inc. | 78,066 | $326.0K | 0.02% | 00.0% | Unchanged |
| Morgan Stanley | 77,609 | $324.0K | 0.00% | −4,677−5.7% | Reduced |
| Tekla Capital Management LLC | 43,394 | $181.0K | 0.01% | 00.0% | Unchanged |
| Sectoral Asset Management Inc | 38,198 | $159.0K | 0.02% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 25,136 | $104.0K | 0.00% | 00.0% | Unchanged |
| Ergoteles LLC | 11,000 | $46.0K | 0.00% | +11,000 | New |
| BlackRock Inc. | 9,553 | $40.0K | 0.00% | −404,703−97.7% | Reduced |
| JPMorgan Chase & Co | 4,352 | $18.0K | 0.00% | +1,361+45.5% | Added |
| Bank Julius Baer & Co. Ltd, Zurich | 2,000 | $8.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,160 | $5.00K | 0.00% | −1,494−56.3% | Reduced |
| TD Waterhouse Canada Inc. | 875 | $4.52K | 0.00% | +875 | New |
| Royal Bank of Canada | 850 | $4.00K | 0.00% | −1,500−63.8% | Reduced |
| Signaturefd, LLC | 300 | $1.00K | 0.00% | 00.0% | Unchanged |
| American Portfolios Advisors | 30 | $125 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 47 | $0 | 0.00% | −4,251−98.9% | Reduced |
| Millennium Management LLC | 0 | $0 | 0.00% | −26,925−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −20,149−100.0% | Sold out |
| DekaBank Deutsche Girozentrale | 0 | $0 | 0.00% | −13,000−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −2,414−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −1,401−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −1,460−100.0% | Sold out |
| Penserra Capital Management LLC | 0 | $0 | 0.00% | −980−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −240−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −78−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| TPG Group Holdings (SBS) Advisors, Inc. | – | – | – | – | Not filed |